Krivorotko, P., Imyanitov, E., Enaldieva, D., Sokolenko, A., Donskih, R., Gigolaeva, L., Gorina, A., Dzhelialova, M., Semiglazova, T., Semiglazov, V. (2026). Neoadjuvant mitomycin C plus carboplatin followed by paclitaxel vs. standard doxorubicin–cyclophosphamide followed by paclitaxel–carboplatin in BRCA1/2-associated breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.620